Human POLE Gene Mutation Detection Kit

qPCR-based kit for detection of 6 POLE mutations in solid tumors. Provides cost-effective POLE mutation analysis on standard real-time PCR systems.

Comprehensive analysis kit for detection of 19 defined mutations within POLE and POLD1 genes. Identifies polymerase-associated mutations relevant to tumor biology and treatment response.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

Molecular diagnostic kit for identification of specific genetic mutations associated with disease or resistance. Enables targeted diagnostic and therapeutic decision-making.

A diagnostic kit developed using gene detection technology and molecular biology methods for genomic analysis. Applicable in disease screening and diagnostic evaluation across clinical laboratory settings.

Diagnostic kit using PCR methodology for identifying genetic mutations and polymorphisms. Supports clinical diagnosis of genetic disorders and carrier screening.

CE IVD real-time PCR kit for detection of APOB R3500Q mutation in human genomic DNA. Supports diagnosis of familial defective apolipoprotein B-100 and lipid disorder assessment.

Molecular diagnostic kit for detecting human genetic markers or species identification. Designed for human-specific molecular testing applications.

Diagnostic kit for detecting relevant mutations in colorectal cancer tissue samples. Identifies mutations affecting prognosis and treatment selection.

A diagnostic test kit designed to detect mutations associated with colorectal cancer. This panel enables identification of genetic alterations relevant to colorectal cancer diagnosis and management.

Diagnostic test kit for identification of genetic mutations and inherited disorders through nucleic acid sequencing. Supports clinical genetic testing and carrier screening applications.

A molecular diagnostic kit for PIK3CA mutation detection. Used in solid tumour oncology for identifying phosphatidylinositol 3-kinase gene mutations in patient samples.